German Tapia1, Ketil Størdal1,2, Karl Mårild1,3, Christian R Kahrs2, Torild Skrivarhaug4,5, Pål R Njølstad6,7, Geir Joner4,5, Lars C Stene1. 1. Department of Child Health, Norwegian Institute of Public Health, Oslo, Norway. 2. Pediatric Department, Østfold Hospital Trust, Grålum, Norway. 3. Barbara Davis Center, University of Colorado, Aurora, CO, USA. 4. Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. 5. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 6. KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway. 7. Department of Pediatrics and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway.
Abstract
Background: Infections in early life have been linked to type 1 diabetes (T1D) risk, but no previous study has comprehensively analysed exposure to antibiotics, acetaminophen and infections during pregnancy and early childhood in relation to offspring risk of T1D. Methods: Participants in the Norwegian Mother and Child Cohort Study (n = 114 215 children, of whom 403 children were diagnosed with T1D) reported infections and medication use through repeated questionnaires from pregnancy until the children were 18 months old. Adjusted hazard ratios (aHR) for offspring T1D were estimated through Cox regression adjusted for child's sex, maternal age and parity, maternal T1D, smoking in pregnancy, education level, pre-pregnancy body mass index (BMI) and birthweight. Antibiotic use was also analysed in a population-based register cohort of 541 036 children of whom 836 developed T1D. Results: Hospitalization for gastroenteritis during the first 18 months of life was associated with increased risk (aHR 2.27, 95% CI 1.21 - 4.29, P = 0.01) of T1D. Childhood infections not requiring hospitalization, or any kind of maternal infection during pregnancy, did not predict offspring risk of T1D. Antibiotic or acetaminophen use in pregnancy, or child`s use in early childhood, was not associated with risk of T1D. Conclusions: Our study, which is population-based and the largest of its kind, did not find support for general early life infections, infection frequency or use of antibiotics or acetaminophen to play a major role in childhood T1D. Hospital admission for gastroenteritis was associated with T1D risk, but must be interpreted cautiously due to scarcity of cases.
Background: Infections in early life have been linked to type 1 diabetes (T1D) risk, but no previous study has comprehensively analysed exposure to antibiotics, acetaminophen and infections during pregnancy and early childhood in relation to offspring risk of T1D. Methods:Participants in the Norwegian Mother and Child Cohort Study (n = 114 215 children, of whom 403 children were diagnosed with T1D) reported infections and medication use through repeated questionnaires from pregnancy until the children were 18 months old. Adjusted hazard ratios (aHR) for offspring T1D were estimated through Cox regression adjusted for child's sex, maternal age and parity, maternal T1D, smoking in pregnancy, education level, pre-pregnancy body mass index (BMI) and birthweight. Antibiotic use was also analysed in a population-based register cohort of 541 036 children of whom 836 developed T1D. Results: Hospitalization for gastroenteritis during the first 18 months of life was associated with increased risk (aHR 2.27, 95% CI 1.21 - 4.29, P = 0.01) of T1D. Childhood infections not requiring hospitalization, or any kind of maternal infection during pregnancy, did not predict offspring risk of T1D. Antibiotic or acetaminophen use in pregnancy, or child`s use in early childhood, was not associated with risk of T1D. Conclusions: Our study, which is population-based and the largest of its kind, did not find support for general early life infections, infection frequency or use of antibiotics or acetaminophen to play a major role in childhood T1D. Hospital admission for gastroenteritis was associated with T1D risk, but must be interpreted cautiously due to scarcity of cases.
Authors: A Kilkkinen; S M Virtanen; T Klaukka; M G Kenward; M Salkinoja-Salonen; M Gissler; M Kaila; A Reunanen Journal: Diabetologia Date: 2005-12-13 Impact factor: 10.122
Authors: H U Irgens; J Molnes; B B Johansson; M Ringdal; T Skrivarhaug; D E Undlien; O Søvik; G Joner; A Molven; P R Njølstad Journal: Diabetologia Date: 2013-04-27 Impact factor: 10.122
Authors: Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Catherijne A J Knibbe; Anthonius de Boer; Aukje K Mantel-Teeuwisse Journal: Antimicrob Agents Chemother Date: 2014-06-02 Impact factor: 5.191
Authors: Markus Lundgren; Leigh Johnson Steed; Roy Tamura; Berglind Jonsdottir; Patricia Gesualdo; Claire Crouch; Maija Sjöberg; Gertie Hansson; William A Hagopian; Anette G Ziegler; Marian J Rewers; Åke Lernmark; Jorma Toppari; Jin-Xiong She; Beena Akolkar; Jeffrey P Krischer; Michael J Haller; Helena Elding Larsson Journal: BMC Pediatr Date: 2017-05-16 Impact factor: 2.125
Authors: Dahye Lee; Seulggie Choi; Jooyoung Chang; Young Jun Park; Jae Hyun Kim; Sang Min Park Journal: Endocrine Date: 2022-05-13 Impact factor: 3.925